• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research on a new internal radiation therapy agent targeting for hypoxic tumors.

Research Project

Project/Area Number 14370274
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionUniversity of Fukui (2004)
福井医科大学 (2002-2003)

Principal Investigator

FUJIBAYASHI Yasuhisa  University of Fukui, Biomedical Imaging Research Center, Professor, 高エネルギー医学研究センター, 教授 (50165411)

Co-Investigator(Kenkyū-buntansha) ITOH Harumi  University of Fukui, School of Medicine, Professor, 医学部, 教授 (40026943)
KAWAI Keiichi  Kanazawa University, School of Medicine, Professor, 医学部 福井大学・高エネルギー医学研究センター, 教授 客員教授(併任) (30204663)
FURUKAWA Takako  University of Fukui, Biomedical Imaging Research Center, Associate professor, 高エネルギー医学研究センター, 助教授 (00221557)
KONNO Takashi  University of Fukui, School of Medicine, Associate Professor, 医学部, 助教授 (50225637)
Project Period (FY) 2002 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥13,800,000 (Direct Cost: ¥13,800,000)
Fiscal Year 2004: ¥4,200,000 (Direct Cost: ¥4,200,000)
Fiscal Year 2003: ¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2002: ¥5,900,000 (Direct Cost: ¥5,900,000)
KeywordsCu-64 / beta emitter / cyclotron / tumor / internal radiation therapy / hypoxia / hypoxia / Hypoxia
Research Abstract

Intratumoral distribution of [Cu-64]Cu-diacetyl-bis (N4-methylthiosemicarbazone) (^<64>Cu-ATSM) and fluorine-18 2-fluoro-2-deoxyglucose (^<18>FDG) in mice bearing tumors of four different origins, LLC1, Meth-A, B16 and colon26, were compared to the immunohistochemical staining for proliferating cells (Ki67), blood vessels (CD34 or von Willebrand Factor(vWF)) and apoptotic cells (terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) method). With all the cell lines, ^<64>Cu-ATSM and ^<18>FDG were distributed to different regions of the tumor mass. The immunohistochemical study demonstrated that the high ^<64>Cu-ASTM uptake regions were hypovascular and consisted of tumor cells arrested in cell cycle, while the high ^<18>FGD uptake regions were hypervascular and consisted of proliferating cells. Through our study, it was revealed that one tumor mass contains two regions of different characteristics, which can be distinguished by ^<64>Cu-ATSM and ^<18>FDG. Since hypoxia and cell cycle arrest are critical factors to reduce the sensitivity of tumor to radiation and conventional chemotherapy, regions with such characteristics in tumor should be treated intensively as one of the primary targets. ^<64>Cu-ATSM which can delineate hypoxic and cell cycle arrested regions in tumors can provide valuable information for cancer treatment as well as the possibility to treat such regions directly as an internal radiotherapy reagent.

Report

(4 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • 2002 Annual Research Report
  • Research Products

    (9 results)

All 2005 Other

All Journal Article (3 results) Publications (6 results)

  • [Journal Article] Basic characterization of ^<64>Cu-ATSM as a radiotherapy agent.2005

    • Author(s)
      藤林 康久
    • Journal Title

      Nuclear Medicine & Biology 32(1)

      Pages: 21-28

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Basic characterization of Cu-64-ATSM as a radiotherapy agent.2005

    • Author(s)
      A.Obata, S.Kasamatsu, J.S.Lewis, T.Furukawa, S.Takamatsu J.Toyohara, T.Asai, M.J.Welch, S.G.Adams, H.Saji, Y.Yonekura, Y.Fujibayashi
    • Journal Title

      Nuclear Medicine & Biology 32

      Pages: 21-28

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Basic characterization of ^<64>Cu-ATSM as a radiotherapy agent.2005

    • Author(s)
      藤林 康久
    • Journal Title

      Nuclear Medicine & Biology. 32(1)

      Pages: 21-28

    • Related Report
      2004 Annual Research Report
  • [Publications] 藤林 康久: "Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotron"Nuclear Medicine & Biology. 30(5). 535-539 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 藤林 康久: "Intra-tumoral distribution of (64) Cu-ATSM : a comparison study with FDG"Nuclear Medicine & Biology. 30(5). 529-534 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 藤林 康久: "Different mechanisms of hypoxic injury on white matter and gray matter as revealed by dynamic changes in glucose metabolism in rats"Neuroscience Letter. 353(2). 148-152 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 藤林 康久: "Development of radioiodinated nucleoside analogs for imaging tissue proliferation : comparisons of six 5-iodonucleosides. Nucl Med Biol. 2003 Oct;30(7):687-96"Journal of Nuclear Medicine. 44(10). 1671-1676 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 藤林 康久: "Delineation of Hypoxia in Canine Myocardium Using PET and Copper(II)-Diacetyl-bis(N^4-Methylthiosemicarbazone)"Journal of Nuclear Medicine. 43(11). 1557-1569 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 藤林 康久: "Copper-64-pyruvaldehyde-bis (N^4-methylthiosemicarbazone) for the Prevention of Tumor Growth at Wound Sites following Laparoscopic Surgery"Cancer Research. 62(2). 445-449 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi